Apple Hits ₹8.5L Cr Revenue as iPhone 17 Sales Soar
Apple's Q4 earnings reveal massive ₹8.5 lakh crore revenue and ₹2.3 lakh crore profit as iPhone 17 sales explode. Discover how India's premium smartphone market is fueling this historic growth.
Category : Search result: pharmaceutical earnings
Cipla CEO Change: Achin Gupta Succeeds Umang Vohra
Indian pharmaceutical giant Cipla reveals strategic leadership transition with Achin Gupta succeeding Umang Vohra as Global CEO in September 2024, marking a new era for the company.
FDA Recalls 580K Blood Pressure Meds Over Cancer Risk
Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.
Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Q2 Results: ITC, Swiggy, NTPC, Adani Power Earnings Today
Major Indian companies including ITC, Swiggy, NTPC, and Adani Power declare Q2 earnings today. Get insights into market expectations and performance analysis.
Punjab de-addiction centres sold pills in black market: ED probe
Shocking probe reveals Punjab doctor's de-addiction centres allegedly operated pill trafficking network while claiming to treat addiction. ED uncovers massive pharmaceutical diversion scheme.
Google's AI Boom Fuels Record $102B Q3 Revenue
Alphabet's Q3 2024 earnings smash expectations as artificial intelligence drives unprecedented growth across Google's advertising and cloud divisions, marking a stunning tech comeback.
Meta Profits Crash 52% on $16B Trump Tax Charge
Meta Platforms reports staggering 52% profit decline in Q3 earnings, hit by massive $16 billion legal charge from Trump administration legislation. Revenue growth continues despite Reality Labs losses.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Coal India Q2 profit plunges 32% due to heavy rains
Coal India reports significant 32% drop in Q2 net profit amid production challenges caused by excessive rainfall. Revenue declines 3% as operations face weather-related hurdles.
Eli Lilly & NVIDIA Partner for AI Drug Discovery
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
Q2 Results: L&T, HPCL, RailTel, Coal India Earnings Today
Major Indian companies including L&T, HPCL, RailTel, and Coal India set to announce Q2 FY2025 earnings today. Get insights on market expectations and sector performance in this comprehensive earnings analysis.
Texas Sues Johnson & Johnson Over Tylenol-Autism Link
The state of Texas has filed a lawsuit against Johnson & Johnson and its spin-off Kenvue, alleging the companies failed to warn consumers about potential autism risks associated with Tylenol use during pregnancy. This legal action comes just weeks after f
India's Stock Market Rally: Strong Beyond AI Hype
Discover how robust economic indicators and corporate earnings are fueling India's sustained market growth beyond the artificial intelligence frenzy. Expert analysis reveals why this rally has staying power.
Q2 Results: TVS Motor, Adani Green, Tata Capital Earnings Today
Major Indian companies including TVS Motor, Adani Green Energy, Tata Capital, and Jindal Steel & Power declare Q2 FY2025 earnings today. Get insights into market expectations and performance indicators for these key stocks.
Sanofi India appoints Deepak Arora as Managing Director
Sanofi India announces Deepak Arora as its new Managing Director, bringing extensive pharmaceutical experience to drive growth and innovation in the Indian healthcare market.
India probes anti-dumping of TB drugs from China, Thailand
India initiates anti-dumping investigation on tuberculosis medication imports from China and Thailand following domestic industry complaints about unfair pricing practices affecting local manufacturers.
SafeCure Services IPO: ₹60 Cr Offer Opens Oct 29
Delhi-based pharmaceutical support company SafeCure Services Ltd plans to raise up to ₹60 crore through IPO. Fresh issue of 48 lakh shares priced at ₹60-75 each. Learn key dates and details.
AI Bubble Fears Loom Over Big Tech Earnings
As Big Tech prepares to announce quarterly results, investors question whether the AI boom is sustainable growth or another market bubble waiting to burst.
Q2 Results Today: Adani Energy, IOC, Indus Towers Declare
Major Indian companies including Adani Energy Solutions, Indus Towers, and Indian Oil Corporation set to declare Q2 FY2025 results today. Get complete list and market expectations.
Punjab bans 112 substandard drugs in health safety drive
In a major healthcare move, Punjab government prohibits sale of 112 substandard drugs following quality control tests. Find out which medications are affected and what this means for public health safety.
Novartis Nears $1.7B Avidity Biosciences Acquisition
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.
Wall Street Braces for Fed Decision & Tech Earnings Storm
US markets face their most critical test of 2024 as Federal Reserve policy meeting and Big Tech earnings converge in a high-stakes week that could redefine market trajectory.
Q2 Results 2025: L&T, ITC, Indian Oil Earnings Next Week
Get ready for a blockbuster week as corporate giants including L&T, ITC, Indian Oil, Swiggy, and Adani Green prepare to announce Q2 FY2025 results, setting the tone for market direction.
NCB grills health staff in Amritsar tramadol racket
Narcotics Control Bureau investigates two Punjab Health Department employees for alleged involvement in illegal tramadol distribution network. Shocking revelations emerge during interrogation.
CDSCO flags 112 drugs, spurious cough syrup after child deaths
India's drug regulator CDSCO has flagged 112 medicines for quality violations and issued a nationwide alert about a spurious cough syrup following child fatalities in Madhya Pradesh. Critical safety update for consumers.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Dr. Reddy's Q2 Earnings Beat Estimates, Revenue Rises
Dr. Reddy's Laboratories delivers stellar Q2 FY25 results, beating revenue and profit forecasts. Discover how their pharmaceutical business and nicotine replacement portfolio drove exceptional performance.
FDA Recalls 140K+ Cholesterol Drug Bottles
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
Page 3 of 4